Updated:
inSharerance
inSharerance uses actuarial AI to predict personal lifespan from health-check data for Japanese consumers.
inSharerance
inSharerance provides a direct-to-consumer digital tool that predicts personal longevity using actuarial methods applied to health-check results. The platform ingests diagnostic data, calculates a health-adjusted lifespan, and delivers AI-generated lifestyle recommendations. It addresses the gap between generic population-level mortality assumptions and an individual's specific clinical markers. The service targets the Japanese market, where mandatory annual health checks generate the structured data the model requires. The output equips users with a quantitative estimate of remaining years, surfacing a number that most healthcare providers avoid. Users have reported using the estimate to restructure savings, pension elections, housing decisions, and employment planning. The interface also flags potential drug side effects and prompts discussions with medical professionals. The firm maintains no disclosed office locations, team size, or executive leadership. Its website lists no named principals, no investor backing, and no regulatory registrations. The absence of company and operator disclosure makes it impossible to assess who builds the underlying actuarial models, who controls the data pipeline, or how user health information is stored and protected. inSharerance represents an unusual structural profile: a consumer-facing, actuarial-powered longevity product without any disclosed corporate entity attached to it. This opacity is its defining architectural feature, and it is uncommon for a tool handling sensitive health data and issuing lifespan predictions to operate without named responsibility-holders.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Sector focus
Frequently asked questions
What does inSharerance do?
It converts personal health-check results into an actuarially estimated lifespan and provides AI-driven health recommendations. The tool is consumer-facing and appears designed for the Japanese market, where structured diagnostic data from annual exams is widely available.
Who runs investment decisions at inSharerance?
No investment decision-makers or any personnel are disclosed. The firm's website and available public records list no executives, founders, or operators, making it impossible to identify who controls the platform or its capital.
Is inSharerance structured as a regulated entity?
There is no public evidence of financial or healthcare regulatory registration. The platform's actuarial lifespan estimates and handling of personal health data are delivered without any disclosed compliance framework or named responsible party.
Where does inSharerance source its actuarial data?
The firm's materials state it applies actuarial mathematics to user-provided health-check results, but it does not specify which mortality tables, population datasets, or clinical benchmarks underpin its model.
How does inSharerance handle user health data?
The platform's privacy and data-handling practices are not publicly documented. There are no posted terms of service, privacy policies, or infrastructure disclosures on its website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: